Weight loss and resting energy expenditure in patients with chronic hepatitis C before and during standard treatment

Obesity : Preventing and managing the global epidemic

D. S. Akram, Arne Astrup, Tola Atinmo et al. · Research at the University of Copenhagen (University of Copenhagen) · 2000 · 13K citations

Public Health, Preventive Medicine, Public Health Nutrition +12

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Paul Y. Kwo, Eric Lawitz, Jonathan McCone et al. · The Lancet · 2010 · 704 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Side effects of therapy of hepatitis C and their management

Michael Fried · Hepatology · 2002 · 556 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17